The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.d

Lupus - Lupus syndrome (see also Vd)

Publications

Chang C, Gershwin ME

Drug-induced lupus erythematosus: incidence, management and prevention.

Drug safety. 2011;34(5):357-74

Alloway JA, Salata MP

Quinidine-induced rheumatic syndromes.

Seminars in arthritis and rheumatism. 1995;24(5):315-22

West SG, McMahon M, Portanova JP

Quinidine-induced lupus erythematosus.

Annals of internal medicine. 1984;100(6):840-2

Anderson FP, Wanerka GR

Drug induced systemic lupus erythematosus due to quinidine.

Connecticut medicine. 1972;36(2):84-5